» Articles » PMID: 35879327

Catulin Reporter Marks a Heterogeneous Population of Invasive Breast Cancer Cells with Some Demonstrating Plasticity and Participating in Vascular Mimicry

Overview
Journal Sci Rep
Specialty Science
Date 2022 Jul 25
PMID 35879327
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer is the most commonly diagnosed cancer in women worldwide. The activation of partial or more complete epithelial-mesenchymal transition in cancer cells enhances acquisition of invasive behaviors and expands their generation of cancer stem cells. Increased by EMT plasticity of tumor cells could promote vascular mimicry, a newly defined pattern of tumor microvascularization by which aggressive tumor cells can form vessel-like structures themselves. VM is strongly associated with a poor prognosis, but biological features of tumor cells that form VM remains unknown. Here we show that catulin is expressed in human BC samples and its expression correlates with the tumor progression. Ablation of catulin in hBC cell lines decreases their invasive potential in the 3D assays. Using a novel catulin promoter based reporter we tracked and characterized the small population of invasive BC cells in xenograft model. RNAseq analysis revealed enrichment in genes important for cellular movement, invasion and interestingly for tumor-vasculature interactions. Analysis of tumors unveiled that catulin reporter marks not only invasive cancer cells but also rare population of plastic, MCAM positive cancer cells that participate in vascular mimicry. Ablation of catulin in the xenograft model revealed deregulation of genes involved in cellular movement, and adhesive properties with striking decrease in CD44 which may impact stemness potential, and plasticity of breast cancer cells. These findings show directly that some plastic tumor cells can change the fate into endothelial-like, expressing MCAM and emphasize the importance of catulin in this process and breast cancer progression.

Citing Articles

Plasticity and resistance of cancer stem cells as a challenge for innovative anticancer therapies - do we know enough to overcome this?.

Knopik-Skrocka A, Sempowicz A, Piwocka O EXCLI J. 2024; 23:335-355.

PMID: 38655094 PMC: 11036066. DOI: 10.17179/excli2024-6972.


Phenotypic Transitions the Processes Involved in Regulation of Growth and Proangiogenic Properties of Stem Cells, Cancer Stem Cells and Circulating Tumor Cells.

Kulus M, Farzaneh M, Bryja A, Zehtabi M, Azizidoost S, Gale Dari M Stem Cell Rev Rep. 2024; 20(4):967-979.

PMID: 38372877 PMC: 11087301. DOI: 10.1007/s12015-024-10691-w.


Emerging Roles of the α-Catenin Family Member α-Catulin in Development, Homeostasis and Cancer Progression.

Gielata M, Karpinska K, Pieczonka T, Kobielak A Int J Mol Sci. 2022; 23(19).

PMID: 36233261 PMC: 9569426. DOI: 10.3390/ijms231911962.

References
1.
Alonso-Alconada L, Muinelo-Romay L, Madissoo K, Diaz-Lopez A, Krakstad C, Trovik J . Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer. Mol Cancer. 2014; 13:223. PMC: 4190574. DOI: 10.1186/1476-4598-13-223. View

2.
Ghajar C . Metastasis prevention by targeting the dormant niche. Nat Rev Cancer. 2015; 15(4):238-47. PMC: 4842412. DOI: 10.1038/nrc3910. View

3.
Liang C, Chiu S, Hsu I, Wu Y, Tsai Y, Ke J . α-Catulin drives metastasis by activating ILK and driving an αvβ3 integrin signaling axis. Cancer Res. 2012; 73(1):428-38. DOI: 10.1158/0008-5472.CAN-12-2095. View

4.
Wiesner C, Winsauer G, Resch U, Hoeth M, Schmid J, van Hengel J . Alpha-catulin, a Rho signalling component, can regulate NF-kappaB through binding to IKK-beta, and confers resistance to apoptosis. Oncogene. 2007; 27(15):2159-69. DOI: 10.1038/sj.onc.1210863. View

5.
Chen B, Liu P, Wang S, Ge Q, Zhan H, Mohler W . α-Catulin CTN-1 is required for BK channel subcellular localization in C. elegans body-wall muscle cells. EMBO J. 2010; 29(18):3184-95. PMC: 2944068. DOI: 10.1038/emboj.2010.194. View